Please use this identifier to cite or link to this item:
https://doi.org/10.1155/2016/7425628
DC Field | Value | |
---|---|---|
dc.title | HCV-Induced Oxidative Stress: Battlefield-Winning Strategy | |
dc.contributor.author | Rebbani, K | |
dc.contributor.author | Tsukiyama-Kohara, K | |
dc.date.accessioned | 2020-10-26T05:21:50Z | |
dc.date.available | 2020-10-26T05:21:50Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Rebbani, K, Tsukiyama-Kohara, K (2016). HCV-Induced Oxidative Stress: Battlefield-Winning Strategy. Oxidative Medicine and Cellular Longevity 2016 : 7425628. ScholarBank@NUS Repository. https://doi.org/10.1155/2016/7425628 | |
dc.identifier.issn | 19420900 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/179979 | |
dc.description.abstract | About 150 million people worldwide are chronically infected with hepatitis C virus (HCV). The persistence of the infection is controlled by several mechanisms including the induction of oxidative stress. HCV relies on this strategy to redirect lipid metabolism machinery and escape immune response. The 3β-hydroxysterol Δ24-reductase (DHCR24) is one of the newly discovered host markers of oxidative stress. This protein, as HCV-induced oxidative stress responsive protein, may play a critical role in the pathogenesis of HCV chronic infection and associated liver diseases, when aberrantly expressed. The sustained expression of DHCR24 in response to HCV-induced oxidative stress results in suppression of nuclear p53 activity by blocking its acetylation and increasing its interaction with MDM2 in the cytoplasm leading to its degradation, which may induce hepatocarcinogenesis. © 2016 Khadija Rebbani and Kyoko Tsukiyama-Kohara. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | Acetylation | |
dc.subject | Cytology | |
dc.subject | Enzyme activity | |
dc.subject | Machinery | |
dc.subject | Viruses | |
dc.subject | Chronic infection | |
dc.subject | Hepatitis C virus | |
dc.subject | Hepatocarcinogenesis | |
dc.subject | Immune response | |
dc.subject | Lipid metabolisms | |
dc.subject | Liver disease | |
dc.subject | Winning strategy | |
dc.subject | Oxidative stress | |
dc.subject | 3beta hydroxysterol delta24 reductase | |
dc.subject | oxidoreductase | |
dc.subject | unclassified drug | |
dc.subject | antioxidant | |
dc.subject | antivirus agent | |
dc.subject | biological marker | |
dc.subject | DHCR24 protein, human | |
dc.subject | MDM2 protein, human | |
dc.subject | nerve protein | |
dc.subject | oxidoreductase | |
dc.subject | protein MDM2 | |
dc.subject | protein p53 | |
dc.subject | TP53 protein, human | |
dc.subject | dendritic cell | |
dc.subject | endoplasmic reticulum | |
dc.subject | Hepatitis B virus | |
dc.subject | hepatitis C | |
dc.subject | Hepatitis C virus | |
dc.subject | human | |
dc.subject | liver cell carcinoma | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | Review | |
dc.subject | stellate cell | |
dc.subject | acetylation | |
dc.subject | animal | |
dc.subject | complication | |
dc.subject | drug effects | |
dc.subject | Hepacivirus | |
dc.subject | Hepatitis C, Chronic | |
dc.subject | host pathogen interaction | |
dc.subject | liver tumor | |
dc.subject | metabolism | |
dc.subject | pathogenicity | |
dc.subject | protein degradation | |
dc.subject | signal transduction | |
dc.subject | virology | |
dc.subject | Acetylation | |
dc.subject | Animals | |
dc.subject | Antioxidants | |
dc.subject | Antiviral Agents | |
dc.subject | Biomarkers | |
dc.subject | Carcinoma, Hepatocellular | |
dc.subject | Hepacivirus | |
dc.subject | Hepatitis C, Chronic | |
dc.subject | Host-Pathogen Interactions | |
dc.subject | Humans | |
dc.subject | Liver Neoplasms | |
dc.subject | Nerve Tissue Proteins | |
dc.subject | Oxidative Stress | |
dc.subject | Oxidoreductases Acting on CH-CH Group Donors | |
dc.subject | Proteolysis | |
dc.subject | Proto-Oncogene Proteins c-mdm2 | |
dc.subject | Signal Transduction | |
dc.subject | Tumor Suppressor Protein p53 | |
dc.type | Review | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.description.doi | 10.1155/2016/7425628 | |
dc.description.sourcetitle | Oxidative Medicine and Cellular Longevity | |
dc.description.volume | 2016 | |
dc.description.page | 7425628 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1155_2016_7425628.pdf | 1.35 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License